Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes using incidence data collected by central cancer registries (through 2020) and mortality data collected by the National Center for Health Statistics (through 2021). In 2024, 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States. Cancer mortality continued to decline through 2021, averting over 4 million deaths since 1991 because of reductions in smoking, earlier detection for some cancers, and improved treatment options in both the adjuvant and metastatic settings. However, these gains are threatened by increasing incidence for 6 of the top 10 cancers. Incidence rates increased during 2015–2019 by 0.6%–1% annually for breast, pancreas, and uterine corpus cancers and by 2%–3% annually for prostate, liver (female), kidney, and human papillomavirus-associated oral cancers and for melanoma. Incidence rates also increased by 1%–2% annually for cervical (ages 30–44 years) and colorectal cancers (ages <55 years) in young adults. Colorectal cancer was the fourth-leading cause of cancer death in both men and women younger than 50 years in the late-1990s but is now first in men and second in women. Progress is also hampered by wide persistent cancer disparities; compared to White people, mortality rates are two-fold higher for prostate, stomach and uterine corpus cancers in Black people and for liver, stomach, and kidney cancers in Native American people. Continued national progress will require increased investment in cancer prevention and access to equitable treatment, especially among American Indian and Alaska Native and Black individuals.

中文翻译：

---

 癌症统计数据，2024 年


每年，美国癌症协会都会估算美国新发癌症病例和死亡人数，并使用中央癌症登记处收集的发病率数据（截至 2020 年）和收集的死亡率数据，汇编有关基于人群的癌症发生和结果的最新数据由国家卫生统计中心提供（截至 2021 年）。 2024 年，美国预计将出现 2,001,140 例新癌症病例和 611,720 例癌症死亡。到 2021 年，癌症死亡率持续下降，由于吸烟的减少、某些癌症的早期发现以及辅助和转移治疗方案的改进，自 1991 年以来避免了超过 400 万人死亡。然而，这些进展受到前 10 种癌症中 6 种发病率上升的威胁。 2015年至2019年间，乳腺癌、胰腺癌和子宫体癌的发病率每年增加0.6%–1%，前列腺癌、肝癌（女性）、肾癌和人乳头瘤病毒相关口腔癌的发病率每年增加2%–3%，黑色素瘤。年轻人中宫颈癌（年龄 30-44 岁）和结直肠癌（年龄<55 岁）的发病率每年也增加 1%-2%。 20 世纪 90 年代末，结直肠癌是 50 岁以下男性和女性癌症死亡的第四大原因，但现在在男性中排名第一，在女性中排名第二。广泛持续的癌症差异也阻碍了进展；与白人相比，黑人的前列腺癌、胃癌和子宫体癌的死亡率以及美洲原住民的肝癌、胃癌和肾癌的死亡率高出两倍。国家的持续进步将需要增加对癌症预防和获得公平治疗的投资，特别是对美洲印第安人、阿拉斯加原住民和黑人而言。